Remove 2026 Remove Digital Health Remove Leadership Remove Telehealth
article thumbnail

Omada Health Becomes the First Fully-Digital Company to Earn URAC Accreditation for Musculoskeletal (MSK) Care

Digital Health Global

Earning this Telehealth Accreditation confirms that Omada Health is meeting the high clinical standards set by URAC,” said Omada Health Chief Medical Officer Carolyn Jasik, MD. Omada for MSK, like Omada’s other programs, integrates high-quality, proactive behavioral health support. In the U.S.,

article thumbnail

Key trends expected to shape Pain Management and Adherence markets in 2024 and beyond

Lloyd Price

Tech-driven Solutions: Digital Therapeutics (DTx): App-based solutions offering personalized pain management programs, education, and support. Telehealth: Remote consultations and monitoring for improved accessibility and convenience. Billion by 2026. The global pain management market is expected to reach $3.3

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

'Roll-Up Strategies to create Platforms' likely to define the HealthTech landscape in 2024

Lloyd Price

Mental Health and Wellness Platforms: Rollups can combine companies offering therapy, counseling, mindfulness apps, and digital therapeutics to create holistic mental health and wellness platforms that address the growing demand for mental healthcare. Email lloyd@nelsonadvisors.co.uk Email lloyd@nelsonadvisors.co.uk

article thumbnail

Average Multiples and Key Drivers of Digital Musculoskeletal (MSK) M&A deals in 2023

Lloyd Price

Despite the decline in valuation multiples, there is still a strong appetite for investment in digital MSK companies. This is due to the growing demand for digital health solutions in the MSK space. HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis.

article thumbnail

What's next for Digital Therapeutics after it all went PEAR shaped?

Lloyd Price

Pear's decline followed in Proteus Digital Health's footsteps after the company filed for bankruptcy in June 2020 having raised over $500 million in funding, a massive $1.5 billion by 2026, growing at a CAGR of 17.8% Billion valuation and loss of a development deal with Otsuka Pharmaceuticals. billion by 2028.